Kita, Aya <br/><br/>
Sepantronium bromide (YM155) enhances response of human B-cell non-Hodgkin lymphoma to rituximab.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Oct 2012 
 - 178-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.112.195925  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Cell Line, Tumor<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Lymphoma, B-Cell--diagnostic imaging<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mice, SCID<br/>Naphthoquinones--administration & dosage<br/>Radionuclide Imaging<br/>Rituximab<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays--methods